Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion type Assertion NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_head.
- NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion description "[Although the monoclonal antibody identified intratumoral heterogeneity, a majority (72%) of NY-BR-1-positive carcinomas revealed immunoreactivity in >50% of the tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_provenance.
- NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion evidence source_evidence_literature NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_provenance.
- NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion SIO_000772 16675566 NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_provenance.
- NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion wasDerivedFrom befree-20140225 NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_provenance.
- NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_assertion wasGeneratedBy ECO_0000203 NP466370.RAGoPxtVlIH1KunVU0_JHgnu9prTSTWWWJhCEkKoWAung130_provenance.